PME.AX
HoldPremium GrowerAI neutralPro Medicus Limited · Healthcare · Australia · $12.0B
AUD 158.09 -0.7% · close 6 Oct · scored 7 Oct
Premium Grower: Strong business with the market behind it, priced at a premium.
Does StockRank work? Each month we publish how every decile did, whichever way it went. See the record →
Pro Medicus sells the Visage imaging software used by major US hospital systems to view and store medical images, with very high margins, no debt and long contracts that renew on usage. It is one of the highest-quality software businesses listed in Australia. The problem is price: the shares trade at an extremely high multiple of earnings, recent commentary questions whether the stock is finally facing a reality check, and any slowdown in contract wins could cause a sharp re-rating.
ABOUT PRO MEDICUS LIMITED
Read
Pro Medicus Limited is a global health imaging IT company that develops and sells advanced medical imaging software, primarily its Visage 7 enterprise imaging platform. The company possesses a strong competitive moat through its highly innovative Visage 7 technology, known for its speed, scalability, and efficiency in handling large imaging datasets. As a niche but highly specialized healthcare technology leader, Pro Medicus is at the forefront of enterprise imaging, serving major hospitals and healthcare networks globally.
FINANCIAL SUMMARY (AUD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2027E | 2028E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 93.4M | 124.8M | 161.4M | 212.9M | 31.6% | 261.1M | 275.5M | 341.6M | 17.1% |
| EPS (AUD) | 0.43 | 0.58 | 0.79 | 1.10 | 37.3% | 2.52 | 1.46 | 1.83 | 18.3% |
| Shares | 104.3M | 104.4M | 104.4M | 104.5M | +0.2% | 104.5M | — | — | — |
| Debt | 2.3M | 1.9M | 2.1M | 2.3M | -0.4% | 2.2M | — | — | — |
| Equity | 101.7M | 138.8M | 187.7M | 257.0M | 36.2% | — | — | — | — |
| Op CF | 61.6M | 62.5M | 82.0M | 111.3M | 21.8% | 127.2M | — | — | — |
| Inv CF | -16.9M | -7.6M | -73.3M | -6.6M | — | — | — | — | — |
| Fin CF | -23.3M | -27.5M | -39.8M | -57.6M | — | — | — | — | — |
Swung more than 69% of stocks we rank over the past year (54% a year).
How this is worked out
What it measures: day-to-day price moves over the past year, as a yearly figure, ranked against every stock we cover. Very calm under 20% a year, Calm 20 to 30%, Average 30 to 40%, Bumpy 40 to 55%, Very bumpy above that.
What we found: across about 13,500 stocks in 34 markets (2002 to 2025), past swings were a good guide to the next year's, and bumpier stocks fell further. How much further changed too much between eras to put a number on it.
Calm is not safe: a calm stock can still slide steadily.
Rules fixed before any data was fetched. Describes the chart, not a recommendation.
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of PME.AX are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| PME.AX | Pro Medicus Limited(you) | $12.0B | 64 | Hold |
| CGS.AX | Cogstate Limited | $394M | 79 | Buy |
| ALC.AX | Alcidion Group Limited | $100M | 61 | Hold |
| RHC.AX | Ramsay Health Care Limited | $9.0B | 73 | Buy |
| COH.AX | Cochlear Limited | $6.5B | 60 | Hold |
| AYA.AX | Artrya Limited | $465M | 12 | Strong Sell |
| SIG.AX | Sigma Healthcare Limited | $21.0B | 58 | Hold |
| EIQ.AX | Echo IQ Limited | $355M | 6 | Strong Sell |
| SHL.AX | Sonic Healthcare Limited | $6.6B | 87 | Strong Buy |
| EBO.AX | EBOS Group Limited | $2.3B | 69 | Buy |
Peer medians: ROE -18.5% · P/E 28.8x · Gross margin 61.2%
Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.